Nasdaq or NYSE related Health Care sector Top Companies List by Market Cap as of January 2024
Nasdaq or NYSE listed Health Care sector Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Health Care sector Largest Companies List by Market Cap as of Jan-05-2024
-
World Rank (Jan-05-2024)9,454Market Cap (Jan-05-2024)0.850 Billion USDWorld Rank (Jul-30-2023)8,056Market Cap (Jul-30-2023)1.147 Billion USDWorld Rank (Dec-25-2022)8,829Market Cap (Dec-25-2022)0.916 Billion USDWorld Rank (Jan-07-2022)5,571Market Cap (Jan-07-2022)2.42 Billion USDAnnual Revenue in USD618 Million USDAnnual Net Income in USD143 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileFulgent Genetics is an accredited leader in Clinical Diagnostic Genetic Sequencing company. The company annual revenue is 135.1 million USD and 123 employees as on 2019. The headquarters is in USA.Company Website
-
Avanos Medical
World Rank (Jan-05-2024)8,536Market Cap (Jan-05-2024)1.008 Billion USDWorld Rank (Jul-30-2023)8,102Market Cap (Jul-30-2023)1.138 Billion USDWorld Rank (Dec-25-2022)7,397Market Cap (Dec-25-2022)1.238 Billion USDWorld Rank (Jan-07-2022)7,172Market Cap (Jan-07-2022)1.61 Billion USDAnnual Revenue in USD820 Million USDAnnual Net Income in USD51 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileAvanos is a Medical Device company. It is focused on delivering clinically superior breakthrough solutions that will help patients get back to the things that matter and develop, manufacture and market recognized brands in more than 90 countries. The headquarters is in USA.
Facts About CompanyAvanos Annual Total Revenue for year ending Dec-2022 was 820 million USD and and Net Income for year ending Dec-2022 was 50 million USD.
Avanos Annual Total Revenue for year ending Dec-2021 was 744 million USD and and Net Income for year ending Dec-2021 was 5 million USD.
As on 2022, Avanos has 4,044 employees.
Company Website -
Mednax
World Rank (Jan-05-2024)9,868Market Cap (Jan-05-2024)0.786 Billion USDWorld Rank (Jul-30-2023)8,107Market Cap (Jul-30-2023)1.137 Billion USDWorld Rank (Dec-25-2022)7,403Market Cap (Dec-25-2022)1.236 Billion USDWorld Rank (Jan-07-2022)5,731Market Cap (Jan-07-2022)2.30 Billion USDAnnual Revenue in USD1,911 Million USDAnnual Net Income in USD130 Million USDAnnual Results for Period EndingDec-2021 ending yearCompany ProfileMednax is a Health Care Organization company. It is a partners with hospitals, health systems and health care facilities to offer clinical services spanning the continuum of care as well as revenue cycle management, patient engagement and perioperative improvement consulting solutions. The headquarters is in USA.Company Website -
Day One Biopharmaceuticals Inc.
World Rank (Jan-05-2024)7,553Market Cap (Jan-05-2024)1.246 Billion USDWorld Rank (Jul-30-2023)8,115Market Cap (Jul-30-2023)1.136 Billion USDWorld Rank (Dec-25-2022)6,738Market Cap (Dec-25-2022)1.431 Billion USDWorld Rank (Jan-07-2022)9,477Market Cap (Jan-07-2022)0.99 Billion USDAnnual Net Income in USD-142 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileDay One Biopharmaceuticals Inc is a clinical stage biopharmaceutical company developing targeted therapies for patients of all ages with life threatening diseases. The headquarters is in USA.Company Website -
RxSight Inc.
World Rank (Jan-05-2024)7,470Market Cap (Jan-05-2024)1.276 Billion USDWorld Rank (Jul-30-2023)8,130Market Cap (Jul-30-2023)1.133 Billion USDWorld Rank (Dec-25-2022)15,145Market Cap (Dec-25-2022)0.329 Billion USDWorld Rank (Jan-07-2022)17,693Market Cap (Jan-07-2022)0.25 Billion USDCompany ProfileRXSIGHT, INC. special lens material designed by a Nobel Prize winning scientist, RxSight has developed the first intraocular lens (IOL) that allows you and your physician to optimize your vision following cataract surgery. Headquarters is in USA.Company Website -
Sana Biotechnology Inc.
World Rank (Jan-05-2024)8,761Market Cap (Jan-05-2024)0.966 Billion USDWorld Rank (Jul-30-2023)8,207Market Cap (Jul-30-2023)1.115 Billion USDWorld Rank (Dec-25-2022)10,819Market Cap (Dec-25-2022)0.647 Billion USDWorld Rank (Jan-07-2022)5,595Market Cap (Jan-07-2022)2.40 Billion USDAnnual Revenue in USD0 Million USDAnnual Net Income in USD-269 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany Website -
P3 Health Partners Inc.
World Rank (Jan-05-2024)10,945Market Cap (Jan-05-2024)0.655 Billion USDWorld Rank (Jul-30-2023)8,208Market Cap (Jul-30-2023)1.115 Billion USDWorld Rank (Dec-25-2022)12,472Market Cap (Dec-25-2022)0.495 Billion USDCompany Website -
Protagonist Therapeutics
World Rank (Jan-05-2024)7,332Market Cap (Jan-05-2024)1.316 Billion USDWorld Rank (Jul-30-2023)8,303Market Cap (Jul-30-2023)1.093 Billion USDWorld Rank (Dec-25-2022)12,464Market Cap (Dec-25-2022)0.496 Billion USDWorld Rank (Jan-07-2022)7,030Market Cap (Jan-07-2022)1.66 Billion USDAnnual Revenue in USD27 Million USDAnnual Net Income in USD-127 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileProtagonist Therapeutics is a Clinical Stage Biopharmaceutical company with multiple peptide based new chemical entities in different stages of development. The headquarters is in USA.
Facts About CompanyProtagonist Therapeutics Annual Total Revenue for year ending Dec-2022 was 26 million USD and and Net loss for year ending Dec-2022 was -127 million USD.
Protagonist Therapeutics Annual Total Revenue for year ending Dec-2021 was 27 million USD and and Net loss for year ending Dec-2021 was -125 million USD.
As on 2022, Protagonist Therapeutics has 105 employees.
Company Website -
Disc Medicine Inc.
World Rank (Jan-05-2024)6,852Market Cap (Jan-05-2024)1.472 Billion USDWorld Rank (Jul-30-2023)8,317Market Cap (Jul-30-2023)1.089 Billion USDCompany Website -
Alignment Healthcare Inc.
World Rank (Jan-05-2024)6,665Market Cap (Jan-05-2024)1.539 Billion USDWorld Rank (Jul-30-2023)8,344Market Cap (Jul-30-2023)1.083 Billion USDWorld Rank (Dec-25-2022)5,212Market Cap (Dec-25-2022)2.144 Billion USDWorld Rank (Jan-07-2022)6,344Market Cap (Jan-07-2022)1.97 Billion USDAnnual Revenue in USD1,434 Million USDAnnual Net Income in USD-149 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileALIGNMENT HEALTHCARE, INC. a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans.
ALIGNMENT HEALTHCARE, INC. coordinates and provides covered health care services, including professional, institutional, and ancillary services to members enrolled in certain benefit plans of unaffiliated Medicare Advantage Health Maintenance Organizations.
Company Website